We serve Chemical Name:(2S,3S,4R,5R)-hexane-1,2,3,4,5,6-hexol CAS:132202-29-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:(2S,3S,4R,5R)-hexane-1,2,3,4,5,6-hexol
CAS.NO:132202-29-0
Synonyms:D-Mannitol-1-13C;<1-13C>Mannitol;MFCD00084008;D-Mannitol-1-13C,1,1-d2
Molecular Formula:C6H14O6
Molecular Weight:183.16400
HS Code:
Physical and Chemical Properties:
Melting point:167-170ºC(lit.)
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:121.38000
Exact Mass:183.08200
LogP:
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:
Contact us for information like D-Mannitol-1-13C chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,D-Mannitol-1-13C,1,1-d2 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,D-Mannitol-1-13C Use and application,D-Mannitol-1-13C,1,1-d2 technical grade,usp/ep/jp grade.
Related News: Wavelength’s growth in the API space comes as nations around the world look to develop redundant supply chains for key generic medicines amid the pandemic. 6-[(3,5-dimethylphenyl)methyl]-2-(1,3-dioxolan-2-ylmethylsulfanyl)-5-ethyl-1H-pyrimidin-4-one manufacturers SARS-CoV-2 has evolved mutations that severely compromise the neutralizing activities of multiple IgG monoclonal antibodies, including those under clinical trials and authorized for emergency use.
Therefore, developing new antibody therapies that can overcome these challenges is an urgent unmet need, and we are pleased with the data published today,” An said.
“Synergizing the strengths of multiple institutions from academia and industry is the key to the rapid translation from ideas to therapeutic candidates.
This is another example of such success. The cross-institutional and academic-industry collaborations should be expanded to other disease indications,” said Pei-Yong Shi, PhD, professor and co-senior author of the study from the Department of Biochemistry and Molecular Biology at UTMB Health.
This antibody has been licensed to biotech partner IGM Biosciences for drug development.
“The ability to use potently neutralizing IgM antibodies against SARS-CoV-2 with broad coverage of VOCs, VOIs, and viral escape mutants, is a very exciting application of the IGM platform,” said Fred Schwarzer, CEO of IGM Biosciences.
“We are grateful to our collaborators at UTHealth, UTMB Health, and our scientists at IGM for the exceptional work described in Nature today. 3-acetoxy-2-ethynylpyridine suppliers According to the Food and Drug Administration and the Orphan Drug Designation program, orphan status applies to drugs and biologics defined as “those intended for the safe and effective treatment, diagnosis or prevention of rare diseases/disorders that affect fewer than 200,000 people in the US, or that affect more than 200,000 people, Octadecanoic acid, 9,14-dihydroxy-, methyl ester vendor & factory.
Therefore, developing new antibody therapies that can overcome these challenges is an urgent unmet need, and we are pleased with the data published today,” An said.
“Synergizing the strengths of multiple institutions from academia and industry is the key to the rapid translation from ideas to therapeutic candidates.
This is another example of such success. The cross-institutional and academic-industry collaborations should be expanded to other disease indications,” said Pei-Yong Shi, PhD, professor and co-senior author of the study from the Department of Biochemistry and Molecular Biology at UTMB Health.
This antibody has been licensed to biotech partner IGM Biosciences for drug development.
“The ability to use potently neutralizing IgM antibodies against SARS-CoV-2 with broad coverage of VOCs, VOIs, and viral escape mutants, is a very exciting application of the IGM platform,” said Fred Schwarzer, CEO of IGM Biosciences.
“We are grateful to our collaborators at UTHealth, UTMB Health, and our scientists at IGM for the exceptional work described in Nature today. 3-acetoxy-2-ethynylpyridine suppliers According to the Food and Drug Administration and the Orphan Drug Designation program, orphan status applies to drugs and biologics defined as “those intended for the safe and effective treatment, diagnosis or prevention of rare diseases/disorders that affect fewer than 200,000 people in the US, or that affect more than 200,000 people, Octadecanoic acid, 9,14-dihydroxy-, methyl ester vendor & factory.
